GSK paid $22.4 million on Sept. 27 for 2.8 million more shares of Wave Life Sciences for $8 each. GSK now owns 16.8 million ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a ...

Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditras | Sanofi has stopped a phase 2 trial of the ...

Zantac was pulled from shelves in 2019 amid panic that a key ingredient - ranitidine - could cause cancer, plunging GSK and ...

GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion: London, UK Friday, October 11, 2024, 14:00 Hrs [IST] GSK plc announced that it has reac ...

The Federal Government of Nigeria has commenced the implementation of zero VAT and excise duties on pharmaceutical products ...

Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity ...

San Antonio attorney Mikal Watts is among a group of lawyers that negotiated a settlement of as much as $2.2 billion to resolve claims by about 80,000 people who allege a discontinued version of the ...